1,398
Participants
Start Date
July 31, 1997
Primary Completion Date
November 30, 2016
Study Completion Date
November 30, 2016
Hydroxyurea
Hydroxyurea (or hydroxycarbamide) is an antineoplastic drug commonly used to treat haematological malignancies.
Aspirin
Aspirin is an anti-aggregating agent, and has been shown to reduce/alleviate minor ischaemic symptoms.
Addenbrooke's Hospital, Cambridge
Cambridge University Hospitals NHS Foundation Trust
OTHER
Institute of Cancer Research, United Kingdom
OTHER
University of Cambridge
OTHER